Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats

Clinical Science

Volumn 122, Issue 11, 2012, Pages 535-543

  Bomfim, Gisele F ^a,b   dos Santos, Rosangela A ^a   Oliveira, Maria Aparecida ^a   Giachini, Fernanda R ^b   Akamine, Eliana H ^a   Tostes, Rita C ^a   Fortes, Zuleica B ^a   Webb, R Clinton ^b   Carvalho, Maria Helena C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cyclo oxygenase; Hypertension; Inflammation; Mesenteric resistance artery; Toll like receptor 4 (TLR4)

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN G2A; INTERLEUKIN 6; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORADRENALIN; THROMBOXANE A2; TOLL LIKE RECEPTOR 4; MEMBRANE PROTEIN; PROSTACYCLIN; PTGS1 PROTEIN, RAT; PTGS2 PROTEIN, RAT; TLR4 PROTEIN, RAT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; ARTERY; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; ARTERIES; BLOOD PRESSURE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPOPROSTENOL; GENE EXPRESSION REGULATION; HEMODYNAMICS; HYPERTENSION; IMMUNITY, INNATE; INTERLEUKIN-6; MALE; MEMBRANE PROTEINS; MESENTERIC ARTERIES; RATS; RATS, INBRED SHR; RATS, WISTAR; THROMBOXANE A2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION;

EID: 84860237455     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110523     Document Type: Article

References (43)

1. Medzhitov, R., Preston-Hurlburt, P. and Janeway, Jr, C. A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
2. Kawai, T. and Akira, S. (2006) TLR signaling. Cell Death Differ. 13, 816-825.
3. Frantz, S., Ertl, G. and Bauersachs, J. (2007) Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 4, 444-454.
4. Frantz, S., Kobzik, L., Kim, Y. D., Fukazawa, R., Medzhitov, R., Lee, R. T. and Kelly, R. A. (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104, 271-280.
5. Pasterkamp, G., Van Keulen, J. K. and De Kleijn, D. P. (2004) Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur. J. Clin. Invest. 34, 328-334.
6. Eissler, R., Schmaderer, C., Rusai, K., Kuhne, L., Sollinger, D., Lahmer, T., Witzke, O., Lutz, J., Heemann, U. and Baumann, M. (2011) Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens. Res. 34, 551-558.
7. El-Achkar, T. M., Plotkin, Z., Marcic, B. and Dagher, P. C. (2007) Sepsis induces an increase in thick ascending limb COX-2 that is TLR4 dependent. Am. J. Physiol. Renal. Physiol. 293, F1187-F1196.
8. Alvarez, Y., Briones, A. M., Balfagon, G., Alonso, M. J. and Salaices, M. (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclo-oxygenase-2 in phenylephrine responses. J. Hypertens. 23, 767-777.
9. Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K. and He, J. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223.
10. Harrison, D. G., Vinh, A., Lob, H. and Madhur, M. S. (2010) Role of the adaptive immune system in hypertension. Curr. Opin. Pharmacol. 10, 203-207.
11. Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J.,Weyand, C. and Harrison, D. G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460.
12. Milanski, M., Degasperi, G., Coope, A., Morari, J., Denis, R., Cintra, D. E., Tsukumo, D. M., Anhe, G., Amaral, M. E., Takahashi, H. K. et al. (2009) Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 29, 359-370.
13. Bautista, L. E. (2003) Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J. Hum. Hypertens. 17, 223-230.
14. Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
15. Liew, F. Y., Xu, D., Brint, E. K. and O'Neill, L. A. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458.
16. Chan, A. C. and Carter, P. J. (2010) Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 10, 301-316.
17. Yang, J., Jiang, H., Ding, J.W., Chen, L. H., Li, S. and Zhang, X. D. (2009) Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-κB signaling pathway. Mol. Cell. Biochem. 330, 39-46.
18. Daubeuf, B., Mathison, J., Spiller, S., Hugues, S., Herren, S., Ferlin, W., Kosco-Vilbois, M., Wagner, H., Kirschning, C. J., Ulevitch, R. and Elson, G. (2007) TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J. Immunol. 179, 6107-6114.
19. Fort, M. M., Mozaffarian, A., Stover, A. G., Correia J., da, S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H. and Probst, P. (2005) A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J. Immunol. 174, 6416-6423.
20. Vila, E. and Salaices, M. (2005) Cytokines and vascular reactivity in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 288, H1016-H1021.
21. Kuper, C., Beck, F. X. and Neuhofer, W. (2012) Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells. Am. J. Physiol. Renal Physiol. 302, F38-F46.
22. Li, D. J., Evans, R. G., Yang, Z.W., Song, S.W., Wang, P., Ma, X. J., Liu, C., Xi, T., Su, D. F. and Shen, F. M. (2011) Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 57, 298-307.
23. Liu, N., Liu, J. T., Ji, Y. Y. and Lu, P. P. (2010) C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells. Life Sci. 87, 367-374.
24. Ohashi, K., Burkart, V., Flohe, S. and Kolb, H. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164, 558-561.
25. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., Stevenson, M. A. and Calderwood, S. K. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034.
26. Pockley, A. G., Wu, R., Lemne, C., Kiessling, R., de Faire, U. and Frostegard, J. (2000) Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36, 303-307.
27. Bautista, L. E. (2005) Association of C-reactive protein with blood pressure. Arterioscler. Thromb. Vasc. Biol. 25, e137.
28. Ji, Y., Liu, J., Wang, Z. and Liu, N. (2009) Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell. Physiol. Biochem. 23, 265-276.
29. Sprague, A. H. and Khalil, R. A. (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 78, 539-552.
30. McCarty, M. F. (1999) Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses 52, 465-477.
31. Gornikiewicz, A., Sautner, T., Brostjan, C., Schmierer, B., Fugger, R., Roth, E., Muhlbacher, F. and Bergmann, M. (2000) Catecholamines up-regulate lipopolysaccharideinduced IL-6 production in human microvascular endothelial cells. FASEB J. 14, 1093-1100.
32. Han, Y., Runge, M. S. and Brasier, A. R. (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors. Circ. Res. 84, 695-703.
33. Turnbull, A. V. and Rivier, C. L. (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79, 1-71.
34. Woods, A., Brull, D. J., Humphries, S. E. and Montgomery, H. E. (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur. Heart J. 21, 1574-1583.
35. Ikeda, U., Ikeda, M., Oohara, T., Oguchi, A., Kamitani, T., Tsuruya, Y. and Kano, S. (1991) Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGFdependent manner. Am. J. Physiol. Heart Circ. Physiol. 260, H1713-H1717.
36. Bautista, L. E., Vera, L. M., Arenas, I. A. and Gamarra, G. (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. J. Hum. Hypertens. 19, 149-154.
37. Alexander, B. T., Cockrell, K. L., Massey, M. B., Bennett, W. A. and Granger, J. P. (2002) Tumor necrosis factor-α-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am. J. Hypertens. 15, 170-175.
38. Granger, J. P. (2006) An emerging role for inflammatory cytokines in hypertension. Am. J. Physiol. Heart Circ. Physiol. 290, H923-H924.
39. Lee, D. L., Sturgis, L. C., Labazi, H., Osborne, Jr, J. B., Fleming, C., Pollock, J. S., Manhiani, M., Imig, J. D. and Brands, M.W. (2006) Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am. J. Physiol. Heart Circ. Physiol. 290, H935-H940.
40. Tabernero, A., Giraldo, J. and Vila, E. (1999) Modelling the changes due to the endothelium and hypertension in the α-adrenoreceptor-mediated responses of rat aorta. J. Auton. Pharmacol. 19, 219-228.
41. Tang, E. H., Jensen, B. L., Skott, O., Leung, G. P., Feletou, M., Man, R. Y. and Vanhoutte, P. M. (2008) The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc. Res. 78, 130-138.
42. Fortes, Z. B., Costa, S. G., Nigro, D., Scivoletto, R., de Oliveira, M. A. and de Carvalho, M. H. (1992) Effect of indomethacin on the microvessel reactivity of two-kidney, one-clip hypertensive rats. Arch. Int. Pharmacodyn. Ther. 316, 75-89.
43. Park, D. W., Baek, K., Lee, J. G., Park, Y. K., Kim, J. H., Kim, J. R. and Baek, S. H. (2007) Activation of Toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling. Biochem. Biophys. Res. Commun. 362, 1090-1095.